Qualitative and quantitative analysis of human herpesviruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma

Leukemia

Volumn 17, Issue 1, 2003, Pages 185-195

  Hermouet, S ^a,b,c   Sutton, C A ^a   Rose, T M ^d   Greenblatt, R J ^a   Corre, I ^b   Garand, R ^c   Neves, A M ^a,e   Bataille, R ^b,c   Casey, J W ^a  

^a Department of Obstetrics Gynecology   (United States)

^b INSTITUT DE BIOLOGIE   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

Human herpesvirus; Lymphocytic leukemia; Multiple myeloma; PCR with consensus degenerate hybrid oligonucleotide primers (CODEHOP); Real time quantitative polymerase chain reaction (qPCR)

Indexed keywords

OLIGONUCLEOTIDE; VIRUS DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE MARROW EXAMINATION; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; GENE SEQUENCE; HERPES VIRUS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RELAPSE; VIRUS LOAD;

EID: 0037265765     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402748     Document Type: Article

References (46)

1. Parsonnet J (ed.). Microbes and malignancy. Infection as a cause of human cancers. Oxford University Press: New York, 1999.
2. Ferreira OC Jr, Planelles V, Rosenblatt JD. Human T-cell leukemia viruses: epidemiology, biology, and pathogenesis. Blood Rev 1997; 1: 91-104.
3. Dammacco F, Sansonno D, Piccoli C, Racanelli V, D'Amore FP, Lauletta G. The lymphoid system in hepatitis C virus infection: auto-immunity, mixed cryoglobulinemia, and overt B-cell malignancy. Semin Liver Dis 2000; 20: 143-157.
4. Silvestri F, Barillari G, Fanin R, Salmaso F, Pipan C, Falasca E, Puglisi F, Mariuzzi L, Zaja F, Infanti L, Patriarca F, Candoni A, Rogato A, Di Loreto C, Botta GA, Baccarani M. Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma. Ann Oncol 1998; 9: 499-504.
5. Oudejans JJ, Jiwa NM, Meijer CJ. Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystander. J Pathol 1997; 4: 353-356.
6. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-1869.
7. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated Herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186-1191.
8. Soulier J, Grollet L, Oksendler E, Cacoub P, Cazals-Atem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L, Sigaux F. Kaposi's sarcoma associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86: 1276-1280.
9. Torelli G, Marasca R, Luppi M, Selleri L, Ferrari S, Narni F, Mariano MT, Federico M, Ceccherini-Nelli L, Bendinelli M, Montagnani G, Montorsi M, Artusi T. Human herpesvirus-6 in human lymphomas: identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction. Blood 1991; 77: 2251-2258.
10. Ohyashiki JH, Abe K, Ojima T, Wang P, Zhou CF, Suzuki A, Ohyashiki K, Yamamoto K. Quantification of human herpesvirus-6 in healthy volunteers and patients with lymphoproliferative disorders by PCR-ELISA. Leukemia Res 1999; 23: 625-630.
11. Quackenbush SL, Casey RN, Murcek RJ, Paul TA, Work TM, Limpus CJ, Chaves A, duToit L, Vasconcelos Perz J, Aguirre AA, Spraker TR, Horrocks JA, Vermeer LA, Balazs GH, Casey JW. Quantitative analysis of Herpesviruses sequences from normal tissues and fibropapillomas of marine turtles with real-time PCR. Virology 2001; 287: 105-111.
12. Lallemand F, Désiré N, Rozenbaum W, Nicolas J-C, Maréchal V. Quantitative analysis of human herpesvirus-8 viral load using a real-time PCR assay. J Clin Microbiol 2000; 38: 1404-1408.
13. VanDevanter DR, Warrener P, Bennett L, Schultz ER, Coulter S, Garber RL, Rose TM. Detection and analysis of diverse herpes viral species by consensus primer PCR. J Clin Microbiol 1996; 34: 1666-1671.
14. Rose TM, Schultz ER, Henikoff JG, Pietrokovski S, McCallum CM, Henikoff S. Consensus-degenerate hybrid oligonucleotide primers for amplification of distantly related sequences. Nucleic Acids Res 1998; 26: 1628-1635.
15. Rose TM, Strand KB, Schultz ER, Schaefer G, Rankin GW, Thouless ME, Tsai CC, Bosch ME. Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 in retroperitoneal fibromatosis of different macaque species. J Virol 1997; 71: 4138-4144.
16. Quackenbush SL, Work TM, Balazs GH, Casey RN, Rovnak J, Chaves A, duToit L, Baines JD, Parrish CR, Bowser PR, Casey JW. Three closely related herpesviruses are associated with fibropapillomatosis in marine turtles. Virology 1998; 246: 392-399.
17. Rovnak J, Quackenbush SL, Reyes RA, Baines JD, Parrish CR, Casey JW. Detection of a novel bovine lymphotropic herpesvirus. J Virol 1998; 72: 4237-4242.
18. Donehower LA, Bohannon RC, Ford RJ, Gibbs RA. The use of primers from highly conserved pol regions to identify uncharacterized retroviruses by the polymerase chain reaction. J Virol Methods 1990; 28: 33-46.
19. Kinlen LJ, Balkwill A. Infective cause of childhood leukemia and wartime population mixing in Orkney and Shetland, UK. Lancet 2001; 357:858.
20. Greaves M. Childhood leukemia. Br Med J 2002; 324: 283-287.
21. European Group for the Immunological classification of acute Leukemias (EGIL): Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB. Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9: 1783-1786.
22. Garand R, Robillard N. Immunophenotypic characterization of acute leukemias and chronic lymphoproliferative disorders: practical recommendations and classification. Hematol Cell Ther 1996; 38: 471-486.
23. Chevallier P, Penther D, Avet-Loiseau H, Robillard N, Ifrah N, Mahé B, Hamidou M, Maisonneuve H, Moreau P, Jardel H, Harousseau J-L, Bataille R, Garand R. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukemia. Br J Haematol 2002; 116: 142-150.
24. Matutes E, Owusu-Ankomah K, Morilla R, Marco JG, Houlihan A, Que TH, Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640-1645.
25. Challine D, Roudot-Thoraval F, Sarah T, Laperche L, Boisson B, Mauberquez S, Dubernet F, Rigot P, Lefrere F, Mercier B, Brossard Y, Rouet F, Girot R, Loiseau P, Girard D, Claquin J, Loty B, Lerable J, Mariotti M, Pawlotsky JM, Lefrere JJ. Seroprevalence of human herpesvirus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses. Transfusion 2001 41: 1120-1125.
26. Lennett ET, Blackbourne DJ, Levy JA. Antibodies to HHV type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996; 348: 858-861.
27. Hermouet S, Corre I, Gassin M, Bigot-Corbel E, Sutton CA, Casey JW. Implication of hepatitis C virus (HCV) and human herpesvirus-8 (HHV-8) in the pathogenesis of a case of aggressive primary plasma cell leukemia (PCL). N Engl J Med (in press).
28. Black JB, Pellett PE. Human herpesvirus 7. Rev Med Virol 1999; 9: 245-262.
29. Di Luca D, Dolcetti R, Mirandola P, De Re V, Seccherio P, Carbone A, Boiocchi M, Cassai E. Human herpesvirus 6: a survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders. J Infect Dis 1994; 170: 211-215.
30. Luppi M, Barozzi P, Morris C, Maiorana A, Garber R, Bonacorsi G Donelli A, Marasca R, Tabilio A, Torelli G. Human herpesvirus 6 latently infects early bone marrow progenitors in vivo. J Virol 1999; 73: 754-759.
31. Dominici M, Luppi M, Campioni D, Lanza F, Barozzi P, Milani R, Moretti S, Nadali G, Spanedda R, Trovato R, Torelli G, Castoldi G. PCR with degenerate primers for highly conserved DNA polymerase gene of the herpesvinus family shows neiher human herpesvirus-8 nor a related variant in bone marrow stromal cells from multiple myeloma patients. Int J Cancer 2000; 86: 76-82.
32. Pan L, Milligan L, Michaeli J, Cesarman E, Knowles DM. Polymerase-chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma. J Mol Diagn 2001; 3: 32-38.
33. Erlach KC, Podlech J, Rojan A, Reddehase MJ. Tumor control in a model of bone marrow transplantation and acute liver-infiltrating B-cell lymphoma: an unpredicted novel function of cytomegalovirus. J Virol 2002; 76: 2857-2870.
34. Vieira J, O'Hearn P, Kimball L, Chandran B, Corey L. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J Virol 2001; 75: 1378-1386.
35. Galloway DA, McDougall JK. The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism. Nature 1983; 302: 21-24.
36. Shen Y, Zhu H, Shenk T. Human cytomegalovirus IE1 and IE2 proteins are mutagenic and mediate 'hit-and-run' oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci USA 1997; 94: 3341-3345.
37. Luppi M, Barozzi P, Schulz TF, Setti G, Staskus K, Trovato R, Narni F, Donelli A, Maiorana A, Marasca R, Sandrini S, Torelli G. Bone marrow failure associated with human herpesvirus-8 infection after transplantation. N Engl J Med 2000; 343: 1378-1385.
38. Luppi M, Barozzi P, Schulz TF, Trovato R, Setti G, Donelli A, Narni F, Sheldon J, Marasca R, Torelli G. Nonmalignant disease associated with human herpesvirus-8 reactivation in patients who have undergone autologous peripheral blood stem cell transplantation. Blood 2000; 96: 2355-2357.
39. Ljungman P, Wang FZ, Clark DA, Emery VC, Remberger M, Ringden O, Linde A. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogenic stem cell transplant patients. Br J Haematol 2000; 111: 774-781.
40. Broers AE, van Der Holt R, van Esser JW, Gratama JW, Henzen-Logman S, Kuenen-Boumeester V, Lowenberg B, Cornelissen JJ. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogenic T-cell depleted stem cell transplantation. Blood 2000; 95: 2240-2245.
41. Cornelissen JJ, Carston M, King R, Dekker AW, Lowenberg B, Anasetti C. Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome. Blood 2001; 97: 1572-1577,
42. van Esser JW, van der Holt B, Meijer E, Niester HG, Trenschel R, Thijsen SF, van Loon AM, Frassoni F, Bacigalupo A, Schaefer UW, Osterhaus AD, Gratama JW, Lowenberg B, Verdonck LF, Cornelissen JJ. Epstein-Barr virus (EBV) reactivation is a frequent event after allogenic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 2001; 98: 972-978.
43. Nanbo A, Inoue K, Adachi-Takasawa K, Takada K. Epstein-Barr virus RNA confers resistance to interferon-α-induced apoptosis in Burkitt's lymphoma. EMBO J 2002; 21: 954-965.
44. Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, Saah A, Phair J, Detels R, Parry P, Chang Y, Moore P. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996; 335: 233-241.
45. Hisada M, Biggar RJ, Greene MH, Fraumeni JF, Travis LB. Solid tumors after chronic lymphocytic leukemia. Blood 2001; 98: 1979-1981.
46. MacKenzie J, Gallagher A, Clayton RA, Perry J, Eden OB, Ford AM, Greaves MF, Jarrett RF. Screening for herpesvirus genomes in common acute lymphoblastic leukemia. Leukemia 2001; 15: 415-421.